Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | KIF11 | P52732 | 6/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzylcysteine SCHEMBL515922 | 1.00 | ALPI (0.58) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Benzylcysteine SCHEMBL1927561 | 1.00 | ALPI (0.58) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Benzylcysteine SCHEMBL6467919 | 0.98 | IDO1 (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Benzylcysteine SCHEMBL3310198 | 0.98 | IDO1 (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Benzylcysteine SCHEMBL1927885 | 0.92 | ACE (0.52) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Benzylcysteine SCHEMBL11584241 | 0.92 | ALPI (0.50) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL11716969 | 0.91 | ALPI (0.53) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL11716975 | 0.91 | ALPI (0.53) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL11871186 | 0.90 | KIF11 (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL5695568 | 0.90 | KIF11 (0.56) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 465 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441765-B2 | Peptides and medical uses thereof | ANBITION S.R.L. (IT) | 2025-10-14 | — | — | US | claimed |
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116655730-A | Derivatives of N-caproic acid-L-tyrosine-L-isoleucine- (6) -aminocaproamide for the treatment of various diseases | 雅斯娜 | 2023-08-29 | — | — | CN | claimed |
| CN-116120936-A | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2023-05-16 | — | — | CN | claimed |
| WO-2022162030-A1 | PEPTIDES FOR INHIBITING ANGIOGENESIS | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2022-08-04 | — | — | WO | claimed |
| CN-113880910-A | Preparation method of synthetic glutathione | 浙江恒腾福生物科技集团有限公司 | 2022-01-04 | — | — | CN | claimed |
| EP-3849582-A1 | PEPTIDES AND MEDICAL USES THEREOF | Anbition S.r.l. (IT) | 2021-07-21 | — | — | EP | claimed |
| EP-3849583-A1 | PEPTIDES AND MEDICAL USES THEREOF | Anbition S.r.l. (IT) | 2021-07-21 | — | — | EP | claimed |
| WO-2020053773-A1 | PEPTIDES AND MEDICAL USES THEREOF | ANBITION S.R.L. (IT) | 2020-03-19 | — | — | WO | claimed |
| WO-2020053772-A1 | PEPTIDES AND MEDICAL USES THEREOF | ANBITION S.R.L. (IT) | 2020-03-19 | — | — | WO | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | claimed |
| EP-0235064-A2 | Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing UVB and/or UVA | Robert, Dominique (FR) | 1987-09-02 | — | — | EP | claimed |
| WO-1987004923-A2 | AROMATIC AMIDES ABSORBING THE U.V. | ROBERT DOMINIQUE | 1987-08-27 | — | — | WO | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| EP-0076557-B1 | PEPTIDES AND PSEUDOPEPTIDES IN WHICH THE N TERMINUS BEARS TWO SUBSTITUENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-11-13 | — | — | EP | claimed |
| US-4483807-A | Process for producing a slow release composite | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1984-11-20 | — | — | US | claimed |
| US-4421744-A | OPIATE RECEPTOR ANTAGONISTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-12-20 | — | — | US | claimed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441765-B2 | Peptides and medical uses thereof | FLT1, FLT4, TEK | ALPI 3479/4885PKM 1870/4885PTGS1 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.